Permanne B[Author] - Search Results

Year	Number of Results
1995	2
1997	2
2000	3
2001	2
2002	2
2012	1
2013	2
2022	1

1

Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?

Permanne B, Adessi C, Fraga S, Frossard MJ, Saborio GP, Soto C. Permanne B, et al. J Neural Transm Suppl. 2002;(62):293-301. doi: 10.1007/978-3-7091-6139-5_27. J Neural Transm Suppl. 2002. PMID: 12456072 Review.

2

O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.

Permanne B, Sand A, Ousson S, Nény M, Hantson J, Schubert R, Wiessner C, Quattropani A, Beher D. Permanne B, et al. ACS Chem Neurosci. 2022 Apr 20;13(8):1296-1314. doi: 10.1021/acschemneuro.2c00057. Epub 2022 Mar 31. ACS Chem Neurosci. 2022. PMID: 35357812 Free PMC article.

3

Development and characterization of a novel membrane assay for full-length BACE-1 at pH 6.0.

Saric A, Brügge Lz, Müller-Pompalla D, Rysiok T, Ousson S, Permanne B, Quattropani A, Busch M, Beher D, Hussain I. Saric A, et al. Among authors: permanne b. J Biomol Screen. 2013 Mar;18(3):277-85. doi: 10.1177/1087057112462237. Epub 2012 Sep 27. J Biomol Screen. 2013. PMID: 23023105

4

Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology.

Ousson S, Saric A, Baguet A, Losberger C, Genoud S, Vilbois F, Permanne B, Hussain I, Beher D. Ousson S, et al. Among authors: permanne b. J Neurochem. 2013 May;125(4):610-9. doi: 10.1111/jnc.12129. Epub 2013 Jan 18. J Neurochem. 2013. PMID: 23253155 Free article.

5

In vivo reversal of amyloid-beta lesions in rat brain.

Sigurdsson EM, Permanne B, Soto C, Wisniewski T, Frangione B. Sigurdsson EM, et al. Among authors: permanne b. J Neuropathol Exp Neurol. 2000 Jan;59(1):11-7. doi: 10.1093/jnen/59.1.11. J Neuropathol Exp Neurol. 2000. PMID: 10744031

6

Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.

Tokuda T, Calero M, Matsubara E, Vidal R, Kumar A, Permanne B, Zlokovic B, Smith JD, Ladu MJ, Rostagno A, Frangione B, Ghiso J. Tokuda T, et al. Among authors: permanne b. Biochem J. 2000 Jun 1;348 Pt 2(Pt 2):359-65. Biochem J. 2000. PMID: 10816430 Free PMC article.

7

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Saborio GP, Permanne B, Soto C. Saborio GP, et al. Among authors: permanne b. Nature. 2001 Jun 14;411(6839):810-3. doi: 10.1038/35081095. Nature. 2001. PMID: 11459061

8

Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay.

Permanne B, Buée L, David JP, Fallet-Bianco C, Di Menza C, Delacourte A. Permanne B, et al. Brain Res. 1995 Jul 10;685(1-2):154-62. doi: 10.1016/0006-8993(95)00431-o. Brain Res. 1995. PMID: 7583241

9

Presenilin-1 is associated with Alzheimer's disease amyloid.

Wisniewski T, Dowjat WK, Permanne B, Palha J, Kumar A, Gallo G, Frangione B. Wisniewski T, et al. Among authors: permanne b. Am J Pathol. 1997 Aug;151(2):601-10. Am J Pathol. 1997. PMID: 9250173 Free PMC article.

10

Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

Permanne B, Adessi C, Saborio GP, Fraga S, Frossard MJ, Van Dorpe J, Dewachter I, Banks WA, Van Leuven F, Soto C. Permanne B, et al. FASEB J. 2002 Jun;16(8):860-2. doi: 10.1096/fj.01-0841fje. Epub 2002 Apr 10. FASEB J. 2002. PMID: 11967228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results